Top Stories
Top Stories

Walgreens pays $269 million to settle US civil fraud lawsuits

A pedestrian passes in front of a Walgreens Boots Alliance Inc. store in the Hollywood neighborhood of Los Angeles, California.
Christopher Lee | Bloomberg | Getty Images

Walgreens Boots Alliance Inc will pay $269.2 million to settle two U.S. whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs, the U.S. Department of Justice said on Tuesday.

The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs for hundreds of thousands of insulin pens it dispensed to patients it knew did not need them.

Walgreens will also pay $60 million to resolve claims it overbilled Medicaid by failing to disclose and charge the lower drug prices it offered the public through a discount program.

The settlements resolve claims under the federal False Claims Act, and were respectively approved last week by U.S. District Judges Paul Crotty and Paul Oetken, who both sit in Manhattan.

Walgreens admitted and accepted responsibility for the alleged wrongdoing, the settlement agreements show.

Next Article
Key Points
  • Investors can find opportunity in homebuilder stocks, but the sector faces profitability risks, Zelman & Associates CEO Ivy Zelman says.
  • Lennar Corp. and KB Home are buys because they have been "way oversold," she says.
  • Zelman has a hold on stocks such as PulteGroup, Toll Brothers and D.R. Horton Inc.